Solventum Corp reported $4.97B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Align Technology USD 862.03M 39.18M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Cencora USD 77B 7.92B Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Insulet USD 639.7M 2.2M Mar/2026
Solventum Corp USD 4.97B 3.08B Mar/2026
West Pharmaceutical Services USD 2.99B 2.35B Mar/2026
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026